OTCMKTS:CVSI CV Sciences (CVSI) Stock Forecast, Price & News $0.04 0.00 (0.00%) (As of 06/16/2023 ET) Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.04▼$0.0552-Week Range$0.03▼$0.07Volume264,324 shsAverage Volume133,905 shsMarket Capitalization$6.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest About CV Sciences (OTCMKTS:CVSI) StockCV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.Read More CVSI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CVSI Stock News HeadlinesJune 1, 2023 | finance.yahoo.comCV Sciences to Participate in LD Micro Invitational ConferenceMay 15, 2023 | msn.comCV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To KnowJune 17, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>May 15, 2023 | finance.yahoo.comCV Sciences, Inc. Reports First Quarter 2023 Financial ResultsMay 14, 2023 | markets.businessinsider.comCV Sciences earnings: here's what Wall Street expectsMay 9, 2023 | finance.yahoo.comCV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023April 9, 2023 | finance.yahoo.comCV Sciences, Inc. (PNK:CVSI) Q4 2022 Earnings Call TranscriptApril 3, 2023 | finance.yahoo.comCV Sciences, Inc. Introduces New THC OfferingJune 17, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>March 29, 2023 | msn.comCV Sciences FY22 Revenue Declines 19% To $16.2MMarch 29, 2023 | finance.yahoo.comCV Sciences, Inc. Reports Fiscal Year-End 2022 Financial ResultsMarch 28, 2023 | markets.businessinsider.comCV Sciences is about to announce its earnings — here's what to expectMarch 25, 2023 | finance.yahoo.comCV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023March 23, 2023 | finance.yahoo.comCV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco AddictionMarch 21, 2023 | finance.yahoo.comCV Sciences, Inc. Launches New Line of THC-Free Gummies and SoftgelsMarch 4, 2023 | benzinga.comCV Sciences, Inc. Announces Proposed Settlement of Shareholder LitigationJanuary 18, 2023 | finance.yahoo.comCV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection SoftgelsJanuary 14, 2023 | benzinga.comCV Sciences Stock (OTC:CVSI), Quotes and News SummaryDecember 20, 2022 | proactiveinvestors.comCV Sciences seeing strong consumer response to Reserve Collection and Wellness Line of productsNovember 14, 2022 | msn.comWhy Is CV Sciences Stock Up Today?November 14, 2022 | seekingalpha.comCV Sciences, Inc. (CVSI) Q3 2022 Earnings Call TranscriptNovember 14, 2022 | finance.yahoo.comCV Sciences, Inc. Reports Third Quarter 2022 Financial ResultsNovember 8, 2022 | finance.yahoo.comCV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022October 1, 2022 | seekingalpha.comCVSI CV Sciences, Inc.August 25, 2022 | finance.yahoo.comCV Sciences, Inc. Extinguishes Convertible DebtAugust 17, 2022 | stockhouse.comCV Sciences, Inc. Announces Launch of PlusCBD(TM) Reserve Collection SoftgelsAugust 15, 2022 | seekingalpha.comCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2022 Results - Earnings Call TranscriptSee More Headlines Receive CVSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address CVSI Company Calendar Last Earnings3/29/2023Today6/17/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CVSI Previous SymbolNASDAQ:CVSI CUSIPN/A CIK1510964 Webwww.cvsciences.com Phone(866) 290-2157Fax619-876-4321Employees42Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,210,000.00 Net Margins-1.83% Pretax Margin-2.13% Return on Equity-15.47% Return on Assets-2.11% Debt Debt-to-Equity RatioN/A Current Ratio1.60 Quick Ratio0.56 Sales & Book Value Annual Sales$16.20 million Price / Sales0.38 Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-4.01Miscellaneous Outstanding Shares152,100,000Free Float151,922,000Market Cap$6.10 million OptionableNot Optionable Beta0.96 Key ExecutivesMr. Joseph D. Dowling (Age 66)CEO, Sec. & Director Comp: $298.98kMr. Joerg Grasser (Age 48)Chief Financial Officer Comp: $210.47kMr. Tim HitchmanVP of OperationsMr. Jesse KaragianesSr. VP of Revenue GrowthMs. Alyssa DunnOperations Mang.Key CompetitorsCelyad OncologyNASDAQ:CYADRevelation BiosciencesNASDAQ:REVBAytu BioPharmaNASDAQ:AYTUBenitec BiopharmaNASDAQ:BNTCInhibitor TherapeuticsOTCMKTS:INTIView All Competitors CVSI Stock - Frequently Asked Questions How have CVSI shares performed in 2023? CV Sciences' stock was trading at $0.0324 on January 1st, 2023. Since then, CVSI shares have increased by 23.8% and is now trading at $0.0401. View the best growth stocks for 2023 here. Are investors shorting CV Sciences? CV Sciences saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 26,100 shares, a drop of 39.9% from the May 15th total of 43,400 shares. Based on an average daily volume of 385,600 shares, the days-to-cover ratio is currently 0.1 days. View CV Sciences' Short Interest. How were CV Sciences' earnings last quarter? CV Sciences, Inc. (OTCMKTS:CVSI) issued its quarterly earnings results on Wednesday, March, 29th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $3.87 million for the quarter. CV Sciences had a negative trailing twelve-month return on equity of 15.47% and a negative net margin of 1.83%. What other stocks do shareholders of CV Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include Aurora Cannabis (ACB), Cronos Group (CRON), Charlotte's Web (CWBHF), KushCo (KSHB), Organigram (OGI), GW Pharmaceuticals (GWPH), Tilray (TLRY) and Medical Marijuana (MJNA). What is CV Sciences' stock symbol? CV Sciences trades on the OTCMKTS under the ticker symbol "CVSI." How do I buy shares of CV Sciences? Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CV Sciences' stock price today? One share of CVSI stock can currently be purchased for approximately $0.04. How much money does CV Sciences make? CV Sciences (OTCMKTS:CVSI) has a market capitalization of $6.10 million and generates $16.20 million in revenue each year. The company earns $-8,210,000.00 in net income (profit) each year or ($0.02) on an earnings per share basis. How can I contact CV Sciences? CV Sciences' mailing address is 10070 BARNES CANYON ROAD, SAN DIEGO CA, 92121. The official website for the company is www.cvsciences.com. The company can be reached via phone at (866) 290-2157, via email at ir@cvsciences.com, or via fax at 619-876-4321. This page (OTCMKTS:CVSI) was last updated on 6/17/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CV Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.